| Literature DB >> 32421816 |
Pora Kim1, Ke Yiya2, Xiaobo Zhou1,3,4.
Abstract
Among the diverse location of the breakpoints (BPs) of structural variants (SVs), the breakpoints of fusion genes (FGs) are located in the gene bodies. This broken gene context provided the aberrant functional clues to study disease genesis. Many tumorigenic fusion genes have retained or lost functional or regulatory domains and these features impacted tumorigenesis. Full annotation of fusion genes aided by the visualization tool based on two gene bodies will be helpful to study the functional aspect of fusion genes. To date, a specialized tool with effective visualization of the functional features of fusion genes is not available. In this study, we built FGviewer, a tool for visualizing functional features of human fusion genes, which is available at https://ccsmweb.uth.edu/FGviewer. FGviewer gets the input of fusion gene symbols, breakpoint information, or structural variants from whole-genome sequence (WGS) data. For any combination of gene pairs/breakpoints to be involved in fusion genes, the users can search the functional/regulatory aspect of the fusion gene in the three bio-molecular levels (DNA-, RNA-, and protein-levels) and one clinical level (pathogenic-level). FGviewer will be a unique online tool in disease research communities.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32421816 PMCID: PMC7319540 DOI: 10.1093/nar/gkaa364
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Figure 1.Diverse tumorigenic mechanisms of FGs in cancer. (A) Signal transduction with control. The BCR with active promoter and dimerization domain is fused with a kinase domain of ABL1 and it leads to uncontrolled cell proliferation. (B) Target gene activation. If a transactivation domain of EWSR1 or tissue-specific androgen-responsive TMPRSS2 fused with a DNA-binding domain of FLI1 or ERG, it results in target gene activation. (C) Lost protein-protein interaction. MLL fusion proteins lose their interactions with important cellular. (D) Avoid of miRNA regulation. The 3′-UTR region of FGFR3 is truncated due to fusion gene, which can avoid the miRNA regulation. (E) Up-regulation of downstream effectors. Inhibition of STAT5, the downstream factor of NUP214-ABL1 led to leukemia cell death. (F) Gain/loss of cellular regulatory subunit. Due to SS18-SSX fusion gene in the BAF complex subunit, it affected the chromatin accessibility.
The number of identified FGs from SV regions of 116 studies in dbVar. It is sorted by the number of identified FGs of each study
| Study ID | # variant regions | # FGs | Study ID | # variant regions | # FGs | Study ID | # variant regions | # FGs |
|---|---|---|---|---|---|---|---|---|
| nstd151 | 49 339 | 6140 | nstd4 | 2949 | 92 | nstd14 | 368 | 9 |
| nstd102 | 60 993 | 6076 | nstd79 | 64 | 92 | nstd149 | 36 | 8 |
| nstd100 | 70 319 | 3717 | estd229 | 16 676 | 90 | nstd99 | 11 116 | 8 |
| nstd37 | 20 391 | 3097 | estd20 | 20 206 | 85 | nstd141 | 123 | 7 |
| nstd54 | 81 345 | 2392 | nstd158 | 1621 | 85 | nstd51 | 229 | 6 |
| nstd71 | 45 084 | 2313 | estd24 | 1773 | 80 | nstd91 | 148 | 6 |
| nstd113 | 9010 | 1645 | nstd53 | 900 | 77 | estd22 | 780 358 | 5 |
| nstd68 | 5132 | 1103 | estd218 | 5513 | 76 | estd228 | 12 | 5 |
| nstd130 | 39 657 | 1043 | nstd111 | 2233 | 76 | nstd161 | 4 | 5 |
| nstd166 | 373 378 | 1037 | nstd157 | 1907 | 66 | nstd46 | 1183 | 5 |
| nstd122 | 94 923 | 798 | nstd29 | 388 | 66 | estd215 | 28 083 | 4 |
| nstd101 | 3105 | 783 | nstd75 | 927 | 66 | estd232 | 8 | 4 |
| nstd132 | 6173 | 725 | nstd145 | 8237 | 57 | nstd17 | 935 | 4 |
| nstd173 | 23 548 | 583 | nstd41 | 255 | 53 | nstd31 | 226 | 4 |
| nstd86 | 1030 | 528 | nstd73 | 9109 | 51 | nstd43 | 1318 | 4 |
| nstd174 | 38 176 | 455 | nstd97 | 2558 | 50 | nstd49 | 4197 | 4 |
| estd214 | 61 678 | 389 | nstd67 | 7950 | 44 | nstd65 | 1299 | 4 |
| nstd21 | 13 566 | 382 | nstd112 | 15 012 | 36 | nstd143 | 18 | 3 |
| estd1 | 3340 | 370 | nstd156 | 963 | 34 | nstd162 | 99 810 | 3 |
| estd55 | 6862 | 366 | estd206 | 513 | 31 | nstd177 | 22 | 3 |
| nstd85 | 1416 | 358 | estd211 | 100 | 31 | nstd36 | 395 | 3 |
| nstd27 | 13 843 | 357 | estd221 | 699 | 30 | nstd47 | 1167 | 3 |
| estd219 | 68 825 | 345 | estd231 | 7063 | 30 | nstd153 | 8 | 2 |
| nstd106 | 39 678 | 337 | estd49 | 225 | 30 | nstd172 | 4659 | 2 |
| estd59 | 228 871 | 323 | nstd45 | 364 | 30 | nstd28 | 6 | 2 |
| estd224 | 3576 | 245 | nstd82 | 28 214 | 30 | nstd50 | 2637 | 2 |
| nstd84 | 10 376 | 245 | estd208 | 81 | 27 | nstd58 | 7 | 2 |
| estd203 | 4192 | 244 | nstd32 | 119 | 24 | nstd83 | 25 | 2 |
| nstd8 | 791 | 209 | nstd64 | 1383 | 23 | estd210 | 4 | 1 |
| nstd107 | 8440 | 204 | estd225 | 1249 | 22 | estd236 | 7 | 1 |
| nstd12 | 2290 | 183 | estd216 | 879 | 20 | estd3 | 2682 | 1 |
| estd212 | 16 575 | 164 | estd213 | 497 | 17 | nstd1 | 297 | 1 |
| nstd30 | 1428 | 161 | nstd152 | 103 985 | 14 | nstd103 | 130 | 1 |
| estd220 | 3620 | 146 | nstd168 | 16 424 | 14 | nstd125 | 34 | 1 |
| nstd80 | 1512 | 144 | nstd2 | 7458 | 14 | nstd164 | 10 | 1 |
| nstd40 | 689 | 129 | nstd16 | 1290 | 12 | nstd20 | 539 | 1 |
| nstd133 | 246 | 123 | nstd22 | 1319 | 11 | nstd33 | 4 | 1 |
| estd233 | 1026 | 116 | nstd66 | 81 | 10 | nstd42 | 1 | 1 |
| estd201 | 36 558 | 105 | nstd92 | 245 | 10 |
Figure 2.Overview of the FGviewer result page of the TMPRSS2-ERG query search. FGviewer is composed of four levels including DNA-, mRNA-, protein- and pathogenic-levels. Details on individual functions are described with shaded text.